InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,497.35
(
0.26%
)
US TECH 100
19,321.20
(
0.29%
)
Dow Jones
39,266.55
(
0.26%
)
Brent Oil
84.82
(
-0.70%
)
Bitcoin
60,668.17
(
-1.56%
)
Post# of 403064
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

williamssc

Send PM Follow Ignore
Followers 43
Posts 5434
Boards Moderated 0
Alias Born 11/15/2013

williamssc

Re: None

Wednesday, 05/13/2015 8:05:57 PM

Wednesday, May 13, 2015 8:05:57 PM

Post# of 403064
"We are pleased with the meticulous care that Dana-Farber and partners have taken in the clinical trial of Kevetrin providing us with exciting data as we move forward with our plans to engage with the FDA for a mid-stage trial in solid tumors in 2015."

Would this be an expanded Phase1 or something more.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!